The Medical Toxicology Service segmentation by application delineates five primary usage contexts that collectively shape market revenue. Emergency departments represent the largest share, accounting for roughly 38 % of total spend, driven by acute poisoning cases that demand immediate specialist input and rapid antidote administration. Poison control centers contribute about 24 %, reflecting their role in triaging calls, providing remote guidance, and coordinating follow‑up care across jurisdictions. Occupational health units hold a 17 % share, where routine exposure monitoring and preventive toxicology assessments generate steady, contract‑based income. Clinical laboratories account for 13 %, primarily through specialized testing services such as serum toxicant quantification that support diagnostic workflows. Finally, research institutions comprise the remaining 8 %, funding toxicology studies, novel assay development, and educational programs that, while smaller in monetary terms, drive innovation and long‑term market expansion.